Table 1 (Contrave Er 01)
Contrave
Product Images NDC 50090-2945
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Contrave (NDC 50090-2945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Naltrexone Hydrochloride Chemical Structure (Contrave Er 02)
Bupropion Hydrochloride Chemical Structure (Contrave Er 03)
Figure 1 (Contrave Er 04)
This appears to be a graph that shows weight change from baseline over time in weeks for a group taking a weight loss drug called CONTRAVE32/360 and a group taking a placebo. The data is labeled with time points in weeks and a percentage change in weight from baseline. The abbreviation "ITT-LOCF" likely refers to the statistical method used to analyze the data.*
Figure 1 (Contrave Er 05)
This appears to be a chart showing weight change percentages of individuals taking CONTRAVE32360 medication versus a placebo over a course of 52 weeks. The graph includes data points at weeks 12, 16, 20, 24, 28, 32, 36, 40, 44, 48 and 52. The abbreviations ITT-LOCF appears to be related to statistical analysis.*
Figure 1 (Contrave Er 06)
Label Image (Lbl500902945)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
